E1207 - Anionic methacrylate copolymer

Origin

Anionic methacrylate copolymers are synthetic polymers derived from methacrylic acid and its esters. These polymers are created through polymerization processes, resulting in macromolecules with anionic (negatively charged) properties. The specific monomers and polymerization conditions determine the final properties of the copolymer, such as its molecular weight, solubility, and pH-dependent behavior. They are not naturally occurring and are manufactured for specific applications.

Usage

E1207, anionic methacrylate copolymer, is primarily used as a coating agent in pharmaceutical and nutraceutical products. Its main function is to provide enteric coating, which protects the active ingredients of a tablet or capsule from the acidic environment of the stomach. This allows the medication to dissolve and be absorbed in the small intestine, where the pH is higher. This targeted release mechanism is crucial for drugs that are sensitive to stomach acid or that need to be absorbed in a specific part of the digestive tract. It can also be used to mask unpleasant tastes or odors of medications. The amount used is carefully controlled to ensure the desired release profile.

Side Effects

Anionic methacrylate copolymers are generally considered safe for consumption when used as intended in pharmaceutical and nutraceutical applications. They are largely inert and are not absorbed into the bloodstream. The primary concern is potential gastrointestinal irritation in sensitive individuals, although this is rare. Studies have shown that these polymers are generally well-tolerated. However, as with any ingested substance, allergic reactions are possible, although uncommon. No ADI (Acceptable Daily Intake) has been specifically established for E1207, as its use is limited and exposure is minimal.

Regulatory Status

The use of anionic methacrylate copolymers in food and pharmaceutical applications is regulated by various authorities, including the European Medicines Agency (EMA) and the United States Food and Drug Administration (FDA). These agencies evaluate the safety and efficacy of these polymers before they can be used in products available to consumers. The FDA generally recognizes these polymers as safe (GRAS) for specific uses in food-related applications, provided they meet certain purity and quality standards. In Europe, their use is permitted under specific regulations governing food additives and pharmaceutical excipients.